Prosecution Insights
Last updated: November 19, 2026

Tokyo Women'S Medical University

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Tokyo Women'S Medical University manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There are currently 2 pending office actions across the portfolio. This indicates a moderate level of ongoing prosecution activity that requires the management of multiple active files.

The university's filings are distributed among 2 distinct examiners and 2 distinct art units. This spread suggests that the research being patented covers different technical sub-fields within the biotechnology sector. Navigating 2 distinct art units requires the university to adapt to different examiner expectations and procedural environments, which can increase the complexity of the prosecution strategy.

TAKENAKA, RISA is the busiest examiner for the university. This examiner is responsible for 1 pending office action. Since there are 2 pending office actions in total, this examiner handles a portion of the current workload, while the remaining action is managed by a different examiner in a separate art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TAKENAKA, RISA 1 28.0% +100.0%
TINSLEY, BRENDAN THOMAS 1 59.6% +73.1%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18573148 METHOD FOR PRODUCING COMPOSITION FOR CULTURING ANIMAL CELLS, COMPOSITION FOR CULTURING ANIMAL CELLS OBTAINED BY SAID METHOD, AND METHOD FOR CULTURING ANIMAL CELLS USING SAID COMPOSITION FOR CULTURING ANIMAL CELLS TAKENAKA, RISA —
18564864 COMPOSITION FOR CULTURING ALGAE AND ALGAE CULTURING METHOD TINSLEY, BRENDAN THOMAS —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18573148 METHOD FOR PRODUCING COMPOSITION FOR CULTURING ANIMAL CELLS, COMPOSITION FOR CULTURING ANIMAL CELLS OBTAINED BY SAID METHOD, AND METHOD FOR CULTURING ANIMAL CELLS USING SAID COMPOSITION FOR CULTURING ANIMAL CELLS TAKENAKA, RISA —
18564864 COMPOSITION FOR CULTURING ALGAE AND ALGAE CULTURING METHOD TINSLEY, BRENDAN THOMAS —

Top Art Units

Art UnitApps
1632 1
1634 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18573148 METHOD FOR PRODUCING COMPOSITION FOR CULTURING ANIMAL CELLS, COMPOSITION FOR CULTURING ANIMAL CELLS OBTAINED BY SAID METHOD, AND METHOD FOR CULTURING ANIMAL CELLS USING SAID COMPOSITION FOR CULTURING ANIMAL CELLS TAKENAKA, RISA 1632 §103§112DP Non-Final OA — Pending Dec 21, 2023
18564864 COMPOSITION FOR CULTURING ALGAE AND ALGAE CULTURING METHOD TINSLEY, BRENDAN THOMAS 1634 §103§112Other Non-Final OA — Pending Nov 28, 2023

Managing Tokyo Women'S Medical University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Tokyo Women'S Medical University have?

Tokyo Women'S Medical University has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Tokyo Women'S Medical University applications?

Risa Takenaka has the most, with 1 of Tokyo Women'S Medical University's pending office actions.

What technology area are Tokyo Women'S Medical University's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month